Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 08:16 am Purchase | 2026-03-31 | 13G | IMMUNOME INC IMNM | Sirenia Capital Management LP | 6,895,000 6.100% | 6,895,000 (New Position) | Filing History |
| 2026-05-15 08:16 am Purchase | 2026-03-31 | 13G | IBIO INC PAR $0.001 IBIO | Sirenia Capital Management LP | 11,586,340 9.900% | 11,586,340 (New Position) | Filing History |
| 2026-05-15 08:14 am Purchase | 2026-03-31 | 13G | EDESA BIOTECH INC EDSA | Sirenia Capital Management LP | 600,000 7.200% | 600,000 (New Position) | Filing History |
| 2026-05-15 08:13 am Purchase | 2026-03-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | Sirenia Capital Management LP | 2,798,122 5.300% | 2,798,122 (New Position) | Filing History |
| 2026-05-15 08:12 am Purchase | 2026-03-31 | 13G | CYBIN INC HELP | Sirenia Capital Management LP | 3,677,966 7.200% | 3,677,966 (New Position) | Filing History |
| 2026-05-15 08:11 am Purchase | 2026-03-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Sirenia Capital Management LP | 6,831,828 7.500% | 6,831,828 (New Position) | Filing History |
| 2026-05-15 08:10 am Purchase | 2026-03-31 | 13G | C4 THERAPEUTICS INC CCCC | Sirenia Capital Management LP | 23,505,000 9.900% | 23,505,000 (New Position) | Filing History |
| 2026-05-15 08:09 am Purchase | 2026-03-31 | 13G | ANAPTYSBIO INC ANAB | Sirenia Capital Management LP | 1,920,402 6.700% | 1,920,402 (New Position) | Filing History |
| 2026-05-15 08:07 am Purchase | 2026-03-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Sirenia Capital Management LP | 2,591,587 7.900% | 2,591,587 (New Position) | Filing History |
| 2026-05-15 08:06 am Purchase | 2026-03-31 | 13G | XILIO THERAPEUTICS INC XLO | Sirenia Capital Management LP | 1,142,862 9.900% | 1,142,862 (New Position) | Filing History |
| 2026-05-15 08:06 am Purchase | 2026-03-31 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | Sirenia Capital Management LP | 1,297,470 8.800% | 1,297,470 (New Position) | Filing History |
| 2026-05-15 08:05 am Purchase | 2026-03-31 | 13G | Q32 BIO INC QTTB | Sirenia Capital Management LP | 2,057,308 9.900% | 2,057,308 (New Position) | Filing History |
| 2026-05-15 08:04 am Purchase | 2026-03-31 | 13G | PALATIN TECHNOLOGIES INC N PTN | Sirenia Capital Management LP | 2,307,000 9.900% | 2,307,000 (New Position) | Filing History |
| 2026-05-15 08:03 am Purchase | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | Sirenia Capital Management LP | 18,031,333 9.900% | 18,031,333 (New Position) | Filing History |
| 2026-05-15 08:02 am Purchase | 2026-03-31 | 13G | OKYO PHARMA LTD SHS USD OKYO | Sirenia Capital Management LP | 4,054,054 7.700% | 4,054,054 (New Position) | Filing History |
| 2026-05-15 08:00 am Purchase | 2026-03-31 | 13G | KODIAK SCIENCES INC KOD | Sirenia Capital Management LP | 3,495,000 5.700% | 3,495,000 (New Position) | Filing History |